Genetic Studies of Human Apolipoproteins: XIII. Quantitative Polymorphism of Apolipoprotein C-III in the Mayans of the Yucatán Peninsula

Apolipoprotein C-III (APO C-III) is a structural component of very-lowdensity and high-density lipoprotein particles and is an inhibitor of lipoprotein lipase. In a study of genetic variation of apolipoproteins in the Mayan population of the Yucatán peninsula, we observed a quantitative polymorphism...

Full description

Saved in:
Bibliographic Details
Published in:Human heredity 1990-01, Vol.40 (3), p.127-135
Main Authors: Ferrell, R.E., Kamboh, M.I., Majumder, P.P., Valdez, R., Weiss, K.M.
Format: Article
Language:English
Subjects:
Apolipoprotein C-III
Apolipoproteins C - genetics
Biological and medical sciences
Fundamental and applied biological sciences. Psychology
Genetic Variation
Genetics of eukaryotes. Biological and molecular evolution
Humans
Indians, Central American - genetics
Isoelectric Focusing
Original Papers
Polymorphism, Genetic
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Apolipoprotein C-III (APO C-III) is a structural component of very-lowdensity and high-density lipoprotein particles and is an inhibitor of lipoprotein lipase. In a study of genetic variation of apolipoproteins in the Mayan population of the Yucatán peninsula, we observed a quantitative polymorphism in APO C-III levels. This polymorphism is expressed as variation in immunoblot staining intensity following isoelectric focusing and as variation in plasma levels of APO C-III determined by radial immunodiffusion. This variation is consistent with the presence in Mayans of an alíele associated with low levels of plasma APO C-III which we have designated APO C-III*D. Analysis of the distribution of APO C-III levels yields a gene frequency estimate for the deficiency alíele of 0.59. There is a significant positive correlation between total plasma APO C-III levels and total plasma cholesterol and triglyceride levels, the lowest levels of cholesterol and triglycérides being seen in individuals homozygous for the deficiency allele. This observation is consistent with the proposed role of APO C-III in lipoprotein metabolism. Family data to determine whether this deficiency alíele is due to mutation at the APO C-III structural locus were not available. However, molecular analysis using cloned probes from the APO A-I/C-III/A-IV gene cluster revealed no gross DNA rearrangement or deletion of sequences in this region in homozygous deficient individuals.
ISSN:0001-5652
1423-0062
DOI:10.1159/000153919